Przekop, D.; Klapaczynski, J.; Grytczuk, A.; Gruszewska, E.; Gietka, A.; Panasiuk, A.; Golaszewski, S.; Cylwik, B.; Chrostek, L.
Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C. J. Clin. Med. 2021, 10, 3951.
https://doi.org/10.3390/jcm10173951
AMA Style
Przekop D, Klapaczynski J, Grytczuk A, Gruszewska E, Gietka A, Panasiuk A, Golaszewski S, Cylwik B, Chrostek L.
Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C. Journal of Clinical Medicine. 2021; 10(17):3951.
https://doi.org/10.3390/jcm10173951
Chicago/Turabian Style
Przekop, Dagmara, Jakub Klapaczynski, Agnieszka Grytczuk, Ewa Gruszewska, Andrzej Gietka, Anatol Panasiuk, Slawomir Golaszewski, Bogdan Cylwik, and Lech Chrostek.
2021. "Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C" Journal of Clinical Medicine 10, no. 17: 3951.
https://doi.org/10.3390/jcm10173951
APA Style
Przekop, D., Klapaczynski, J., Grytczuk, A., Gruszewska, E., Gietka, A., Panasiuk, A., Golaszewski, S., Cylwik, B., & Chrostek, L.
(2021). Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C. Journal of Clinical Medicine, 10(17), 3951.
https://doi.org/10.3390/jcm10173951